StockData
Aquestive Therapeutics, Inc. logo

Aquestive Therapeutics, Inc. (AQST) stock

AQSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 3/30
$3.70−0.06 (-1.60%)

Close on Nov 17, 2026Market cap $464.39MP/E –Yield –

Aquestive Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Aquestive Therapeutics's operating margin for the twelve months ending Jun 30, 2026 was -97.5%. For fiscal 2025 it was -159.5%, against -53.5% the year before. The highest annual figure on record is -0.2% in fiscal 2017.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-159.5%−106.0
FY2024Dec 31, 2024-53.5%−23.6
FY2023Dec 31, 2023-29.9%+58.4
FY2022Dec 31, 2022-88.2%−20.0
FY2021Dec 31, 2021-68.2%+25.3
FY2020Dec 31, 2020-93.6%+6.6
FY2019Dec 31, 2019-100.1%−27.5
FY2018Dec 31, 2018-72.6%−72.4
FY2017Dec 31, 2017-0.2%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-59.5%+54.1
Q1 FY2026Mar 31, 2026-29.1%+193.0
Q4 FY2025Dec 31, 2025-221.6%−107.2
Q3 FY2025Sep 30, 2025-89.6%−28.4
Q2 FY2025Jun 30, 2025-113.6%−113.9
Q1 FY2025Mar 31, 2025-222.1%−147.8
Q4 FY2024Dec 31, 2024-114.4%−84.8
Q3 FY2024Sep 30, 2024-61.2%−42.9
Q2 FY2024Jun 30, 20240.3%+32.1
Q1 FY2024Mar 31, 2024-74.3%−33.0
Q4 FY2023Dec 31, 2023-29.6%+70.7
Q3 FY2023Sep 30, 2023-18.3%+58.9
Q2 FY2023Jun 30, 2023-31.8%+64.4
Q1 FY2023Mar 31, 2023-41.4%+38.0
Q4 FY2022Dec 31, 2022-100.3%+5.0
Q3 FY2022Sep 30, 2022-77.2%−17.3
Q2 FY2022Jun 30, 2022-96.2%−53.7
Q1 FY2022Mar 31, 2022-79.4%−2.7
Q4 FY2021Dec 31, 2021-105.3%+113.5
Q3 FY2021Sep 30, 2021-60.0%+106.9
Q2 FY2021Jun 30, 2021-42.5%−44.3
Q1 FY2021Mar 31, 2021-76.6%+81.5
Q4 FY2020Dec 31, 2020-218.9%−158.5
Q3 FY2020Sep 30, 2020-166.8%−78.2
Q2 FY2020Jun 30, 20201.8%+169.7
Q1 FY2020Mar 31, 2020-158.1%−54.7
Q4 FY2019Dec 31, 2019-60.3%+13.1
Q3 FY2019Sep 30, 2019-88.6%−111.3
Q2 FY2019Jun 30, 2019-167.9%−108.4
Q1 FY2019Mar 31, 2019-103.4%−141.8
Q4 FY2018Dec 31, 2018-73.4%−37.0
Q1 FY2018Mar 31, 201822.7%–
Q4 FY2017Dec 31, 2017-59.5%–
Q3 FY2017Sep 30, 201738.4%–
Q2 FY2017Jun 30, 2017-36.4%–

More Aquestive Therapeutics figures

See a number that looks wrong?